Fingerprint
Dive into the research topics of 'Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
Sebastian M. Dieter, Christine Siegl, Paula L. Codó, Mario Huerta, Anna L. Ostermann-Parucha, Erik Schulz, Martina K. Zowada, Sylvia Martin, Karin Laaber, Ali Nowrouzi, Mona Blatter, Sina Kreth, Frank Westermann, Axel Benner, Ulrike Uhrig, Kerstin Putzker, Joe Lewis, Andrea Haegebarth, Dominik Mumberg, Simon J. Holton
- National Center for Tumor Diseases (NCT/UCC) Dresden
- German Cancer Research Center
- Merck KGaA
- CureVac
- University Hospital Heidelberg
- Heidelberg University
- Hopp Children's Cancer Center Heidelberg (KiTZ)
- European Molecular Biology Laboratory Heidelberg
- Bayer AG
- Nuvisan Innovation Campus Berlin GmbH
- Universitätsklinikum Carl Gustav Carus Dresden
- OmicScouts GmbH
Research output: Contribution to journal › Article › peer-review
48
Scopus
citations